High Impact Medicine Podcast

Dr Jan Brauner, PhD candidate, discusses AI in medicine, clinical trials, and AI safety. Topics include career transitions from medicine to machine learning, characteristics for AI safety work, future goals in AI and medicine, and unconventional paths in medicine and clinical trials.

Dr. Alastair Yeoh, a Junior Doctor with experience in humanitarian medicine, discusses impact-driven medicine, healthcare disparity in Zambia, preparation for MSF missions, effective charitable giving, career aspirations in infectious diseases, and traits needed for humanitarian work.

Dr Chris Lovejoy is a data scientist and medical doctor in London, passionate about scalable impact through technology and education. Currently, he is in the early stages of starting his own company, backed by Entrepreneur First. He is also a guest lecturer at teaching assistant in machine learning at UCL. We were really excited to talk to him about the potential for impact in medicine through technology and tech entrepreneurship as well through machine learning and data science. Referenced material Little Bets: How Breakthrough Ideas Emerge from Small Discoveries - Peter Sims - book  Machine Learning by Stanford - Andrew Ng  - on Coursera here Preparing the healthcare workforce to deliver the digital future - Topol Review - see here  Do You Feel Like You Wasted All That Training? Answers About Transitioning to Non-Clinical Careers for Physicians - Michael J. McLaughlin - book Dr Chris Lovejoy's Youtube Channel - see here Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again - Eric Topol  - book  CS50's Introduction to Artificial Intelligence with Python - Harvard - course see here 

Dr Lucia Coulter, clinical doctor turned charity founder, discusses charity entrepreneurship and global health on the podcast. Topics include her transition to public health advocacy, motivations behind global health initiatives, daily activities as a charity entrepreneur, essential skills for nonprofit entrepreneurship in global health, and addressing lead exposure in low and middle-income countries.